This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck Serono S. a., Laboratoires Serono S.a., National Institute of Health and Medical Research. Active years: 2008-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Geneva, CH (2008 - 2012)
- Marseilles, FR (2011 - 2015)
Company Filing History:
6 out of 145 
1 out of 40 
1 out of 1,853 
Years Active: 2008-2015
Title: Michel Aurrand-Lions: Innovator in Medical Research
Introduction
Michel Aurrand-Lions is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of medical research, particularly in the development of novel therapeutics. With a total of 8 patents to his name, Aurrand-Lions has focused on addressing critical health issues through innovative solutions.
Latest Patents
One of his latest patents is titled "Antagonists of GRASP55 for use as a medicament." This invention concerns antagonists of the Golgi reassembly-stacking protein of 55 kDa (Grasp55), which are intended for use in treating diseases related to cell adhesion molecules, such as MCAM or JAMs implicated diseases. The patent outlines potential applications in treating cancer, metastases, and inflammatory diseases. Additionally, it provides methods for screening compounds that may treat or prevent these conditions. Another significant patent is "Vascular adhesion molecules and modulation of their function." This invention relates to new polypeptides that belong to a subfamily of the human immunoglobulin superfamily. These polypeptides show at least 70% sequence homology with the amino acid sequence of murine Confluency Regulated Adhesion Molecules 1 or 2 (CRAM-1 or CRAM-2) and their use in treating inflammation and tumors.
Career Highlights
Throughout his career, Michel Aurrand-Lions has worked with notable companies such as Merck Serono S.A. and Laboratoires Serono S.A. His work has significantly impacted the pharmaceutical industry, particularly in the development of treatments for complex diseases.
Collaborations
Aurrand-Lions has collaborated with esteemed colleagues, including Beat Albert Imhof and Pierre-Yves Dietrich. These collaborations have further enhanced his research and innovation in the medical field.
Conclusion
Michel Aurrand-Lions is a distinguished inventor whose work in medical research has led to significant advancements in therapeutic options. His patents reflect a commitment to addressing critical health challenges through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile